Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

RSS icon

Fingleton becomes chief of CV surgery in Mass. health system

James G. Fingleton, MD, has joined Southcoast Health System in Fall River, Mass., as its chief of cardiovascular surgery.

Benefits of Brilinta in ACS patients appear to span into elderly 75+

The significant clinical benefit and overall safety of ticagrelor (Brilinta, AstraZeneca) compared with clopidogrel in acute coronary syndrome (ACS) patients in the PLATO cohort were not found to depend on age. These findings were published in the September issue of Circulation: Cardiovascular Quality and Outcomes.

Abbott launches BVS stent in EU

Abbott's Absorb, a drug-eluting bioresorbable vascular scaffold (BVS) stent, is now available across Europe and parts of Asia Pacific and Latin America.

Thumbnail

Women face higher procedural risks, better long-term outcomes with stenting

Women receiving coronary stents faced higher procedural risk than men, but their long-term survival rates were higher, according to an analysis published online Sept. 17 in Circulation. Outcomes for both genders were better when treated with drug-eluting stents (DES) rather than bare-metal stents (BMS).

When Hospitals Say I do to TAVR

Providers offering this new therapy may require extra resources, but pioneers and relative newcomers agree that it has its rewards.

Model analysis shows promising data for renal denervation's cost-effectiveness

Catheter-based renal denervation, over a wide range of assumptions, is a cost-effective strategy for resistant hypertension and might result in lower cardiovascular morbidity and mortality, according to an assessment using a state-transition, or Markov, model. The study was published in the Sept. 18 edition of the Journal of the American College of Cardiology.

HERCULES can't muscle out answers on renal artery stenting

The inconclusive findings of the HERCULES trial, published in the September issue of Catheterization and Cardiovascular Interventions, have encouraged researchers to continue investigations to see if renal artery stenting is safe and effective in patients with uncontrolled hypertension and atherosclerotic renal artery stenosis.

No survival benefit in keeping tight glucose control in kids in CICU

Although some studies have portrayed tight blood sugar control as a potential means of lowering infection rates in critically ill adults, the SPECS study, published online Sept. 7 in the New England Journal of Medicine, found no indication that the approach benefits pediatric patients undergoing heart surgery. As a result, the editorialist suggested that the door should be closed on routine use of glucose homeostasis in critically ill children.

Displaying 1985 - 1992 of 2712

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.